New directions in the treatment of anxiety disorders

Expert Opinion on Therapeutic Patents

Volumn 10, Issue 4, 2000, Pages 389-402

  Bain, E E ^a   Candilis, P J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

5 HT receptor; Anxiety disorders; Anxiolytic; CCK receptor; Cholecystokinin; Corticotrophin releasing factor; Corticotrophin releasing hormone; GABA; GABA receptor; Neuropeptide Y; Neuropeptides; Serotonin receptor; Tachykinin; Tachykinin receptor

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; SEROTONIN AGONIST;

ANXIETY NEUROSIS; DRUG DESIGN; HUMAN; MORBIDITY; PATENT; REVIEW;

EID: 0034118416     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.10.4.389     Document Type: Review

References (73)